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ABSTRACT 
Thirty two new stemofoline analogues were prepared from didehydrostemofoline for studies 
as AChE inhibitors. C-3 side-chain modified amino, carbamate, triazole and oxazole 
stemofoline derivatives were prepared. In general the amine derivatives were found to be 
stronger inhibitors of AChE than their alcohol analogues that we previously reported. 
Compounds 5 and 26, with small C-3 side chain substituents, were two of the most active 
inhibitors. Preliminary molecular docking studies suggested that these compounds may 
inhibit AChE by binding horizontally along the passage of the active-site gorge and block 







One of the primary roles of acetylcholinesterase (AChE) is the hydrolysis of the 
neurotransmitter acetylcholine (ACh) to inactive choline and acetate in cholinergic synapses. 
Thus AChE is essential for the rapid modulation of synaptic acivity.1 Hydrolysis of ACh 
occurs through a protease-like action of an active site serine residue. This site resides at the 
end of a relatively long and narrow gorge. Inhibitors of AChE can bind irreversibly (for 
example, some pesticides) or reversibly to the active site or at other sites in the gorge (for 
example, the peripheral anionic site (PAS)) and block the access of ACh to the active site.1 
Reversible AChE inhibitors, for example the alkaloid galantamine (reminyl), have been used 
in the treatment of patients with Alzheimer’s disease (AD) to alleviate the symptoms of 
reduced ACh concentration in the brain.2 More recent AD drug development strategies 
involve targeting microtubule-associated τ-protein, metal ion dyshomeostasis and the various 
β-amyloid (Aβ) pathological mechanisms of this disease.2,3 AChE colocalizes with Aβ which 
then promotes and accelerates Aβ aggregation.4-6 This has renewed an intense interest in 
AChE inhibitors, including dual binding AChE inhibitors7 and those that can be activated by 
AChE8 and have Aβ-antiaggregating action. We have recently reported that the Stemona 
alkaloids stemofoline and didehydrostemofoline and some of their C-3 side chain derivatives 
are inhibitors of AChE.9-11 Such activity is most likely associated with the insecticidal 
activity of these alkaloids and the crude extracts of Stemona plants. Our earlier studies 
focused on C-3 hydroxyalkyl derivatives, including the synthesis of rare Stemona alkaloids,  
where it was found that the AChE inhibitory activity was dependent upon the length of the C-
3 alkyl chain, the position of the hydroxyl group and in some cases the configuration of the 
carbinol carbon.10 This study also revealed that the butyrolactone ring of stemofoline was 
essential for AChE inhibitory activity.10 We report here the synthesis of several novel C-3 
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side-chain amino, carbamate, triazole and oxazole stemofoline derivatives and their activities 
as AChE inhibitors. 
  
2. Results and discussion 
2.1 Synthesis of compounds 
 In order to prepare the amine derivatives 3-19, the known aldehyde 2 was prepared 
from didehydrostemofoline 1 (Figure 1), following our previously described procedures9 and 
used as a key scaffold for reductive amination reactions to prepare the 17 amine derivatives 
as shown in Scheme 1.  
 
Figure 1. Didehydrostemofoline 1 and its aldehyde derivative 2 
 
Using the reductive amination procedure described by Abdel-Magid et. al.,12 the amines 3-19 
were obtained in yields ranging from 25-93%. A further methylation reaction of the amine 6 
(Scheme 2) gave the tertiary amine 20 in 94% yield. Carbamylation reactions of the amines 
15-17 (Scheme 3) gave the carbamates 21-23 in yields ranging from 56-80%. The HCl salt of 
the guanidine derivative 25 was prepared in two steps via a key guanidination reaction13 of 






Scheme 1. Synthesis of amine derivatives 3-19. Reagents and conditions: (i) amine, NaBH(OAc)3, CH2Cl2, 
0.1% HOAc, rt, 24 h (yields 25-93%). 
 
 
Scheme 2. Synthesis of amine derivative 20. Reagents and conditions: (i) formaldehyde, NaBH(OAc)3, 
dichloroethane, 0.1% HOAc, rt, 24 h (yield 94%). 
 
 
Scheme 3. Synthesis of amine derivatives 21-23. Reagents and conditions: (i) ethyl chloroformate, 





Scheme 4. Synthesis of guanidine derivative 25. Reagents and conditions: (i) guanidine triflate, CH2Cl2, rt, 24 h; 
(ii) TFA/CH2Cl2 (1:1), rt, 3 h (yield 54%); (iii) precipitated from MeOH by HCl in ether (yield 52%). 
 
Another key scaffold, the alkyne 26, was prepared from a one-step alkynylation 
reaction14 of the aldehyde 2 using the Bestmann-Ohira reagent15,16 (dimethyl-1-diazo-2-
oxopropylphosphonate) which was prepared as described by Ghosh et. al.17 (Scheme 5). 
The 1,3-dipolar cyclization (“click”) reactions of the alkyne 26 (Scheme 6) were examined 
under three different reaction conditions to provide the four triazoles 27-30 and the two 
isoxazoles 31-32 in yields ranging from 18-59%. The alkyne 26 was treated under 
Sonogashira coupling conditions18 to yield the phenyl substituted alkyne 33 in 62% yield and 
the self-condensation product 34 in 4% yield (Scheme 7 (i)). The dimer 34 was more 
effectively obtained in 89% yield under Eglington coupling conditions19 (Scheme 7 (ii)). The 
Sonogashira product 33 was hydrogenated over Pd/C under a H2 atmosphere for 24 h to give 




Scheme 5. Synthesis of the alkyne 26. Reagents and conditions: (i) Bestmann-Ohira reagent 






Scheme 6. Click reactions of the alkyne 26. Reagents and conditions: (i) RBr, NaN3, Cu powder, CuSO4, 
tBuOH/H2O (1:1), MW 125 °C, 10 min (yields 18-23%); (ii) RN3, Cu(OAc)2, sodium ascorbate, MeOH/H2O 




Scheme 7. Synthesis of compounds 33-35. Reagents and conditions: (i) PhI, PdCl2(PPh3)2, CuI, Et3N, THF, N2, 
rt, 24 h (yields 33: 62%, 34: 4%); (ii) Cu(OAc)2, MeCN, argon gas, 40 °C, 4 h (yield 89%); (iii) Pd/C, H2, 
EtOAc, rt, 24 h (yield 74%). 
 
2.2 Biological assays 
We initially used the TLC bioautographic method of Hostettmann20 to determine the 
minimum inhibitory requirements (MIRs) of these compounds against electric eel AChE 
(eeAChE) using galanthamine as a positive control. The results are reported in Tables 1−3. In 
our assay, galanthamine had a MIR of 1 ng. This assay revealed that the carbamate 22 and the 
tertiary amino compound 4 (Table 1, entries 1 and 2) were essentially equipotent to 
galanthamine and more potent than their parent compound didehydrostemofoline 1. The 
secondary amino compounds 19, 5 and 3 and the guanidine derivative 25 were equipotent to 
didehydrostemofoline 1 (Table 1, entries 3−7).  The carbamates 23 and 21 and the secondary 
amines, 13, 18, 16, 17 and 20 and the quaternary amines 9 and 20, all had MIR values of 10 
ng (Table 1, entries 8−18). The dibasic-amino compounds 11 and 17 were the least active 
amine derivatives (Table 1, entries 22 and 23). None of the click products 27−32 (Table 2) 
were as potent as didehydrostemofoline 1 or the amino derivatives in Table 1, entries 1−7. 
The N-benzyl-triazole derivative 27 was the most potent of this series of compounds while 
the others with longer and more flexible linkers (28 and 30) or no linker (29, 31 and 32) 
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between the heterocyclic triazole or isoxazole moiety and the aryl substituent were 
significantly less active.  
The terminal alkyne 26 and the phenylethyl derivative 35 were essentially equipotent 
to galanthamine and didehydrostemofoline 1, respectively (Table 3, entries 1 and 2). 
Substitution of the terminal alkyne CH of 26 with a phenyl group, as in compound 33, had an 
adverse effect on inhibitory activity. The dimer of 26 had very poor activity (Table 3). 
Compared to our earlier results,10 this study showed that in general the amine derivatives 
were more active than our previously reported alcohol derivatives.10  
We attempted to determine the IC50 values of many of the more active compounds, 
and some of the alcohol analogues we reported earlier,10 against eeAChE and human AChE 
(hAChE) using Ellman’s assay.21 We found however, that the majority of these compounds 
were not soluble in the assay medium (DMSO, pH 7.0 phosphate buffer). The IC50 results 
determined on those that were soluble in the assay medium are shown in Table 4. In our 
assay, galanthamine had IC50 values of 0.912 µM and 0.597 µM against eeAChE and hAChE, 
respectively (Table 4, entry 1). Didehydrostemofoline 1 and compound 5, which both had 
MIRs of 5 ng against eeAChE, showed similar IC50 values (ca 12−25 µM) against eeAChE 
and hAChE, which indicated they were significantly less potent than galanthamine (Table 4, 
entries 2 and 3).  Compounds 36,10 8, 9 and 37,10 all with MIRs of 10 ng against eeAChE, 
were less active than compounds 1 and 5 (Table 4, entries 4−7). Their IC50 values against 
eeAChE however, did not correlate as well to their corresponding MIR values. However, 
their IC50 values against hAChE were relatively similar (ca 37−52 µM).   
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Table 1 AChE inhibitory activities of didehydrostemofoline 1 and the amine derivatives 3-23 






















6 1  5 0.013 

























16 6  10 0.025 

















aGalanthamine was used as a positive control having a MIR of 1 ng or 0.003 nmol. 





























aGalanthamine was used as a positive control having a MIR of 1 ng or 0.003 nmol. 
bEntries listed in order of decreasing activity. 
 
 


















aGalanthamine was used as a positive control having a MIR of 1 ng or 0.003 nmol. 
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To inhibit AChE, inhibitors can bind to one or more sites of the enzyme. AChE has 
been reported to have at least two binding sites, the active site and the peripheral anionic site 
(PAS).22 The active site is buried at the bottom of a 20 Å deep narrow gorge23 and includes 
four catalytic subsites, the esteractic site (which contains Ser200, His440 and Glu327), the 
oxyanion hole (which contains Gly118, Gly119 and Ala201), the acyl pocket (which contains 
Phe288 and Phe290) and the anionic subsite (which contains Trp84, Phe330 and Glu199).24 
In contrast, the PAS which consists of Tyr70, Asp72, Tyr121, Tyr334 and Trp279, is located 
at the entrance of the active-site gorge. The binding of ligands to the PAS may block the 
passage of ACh or change the conformation of the active site allosterically and inhibit its 
function.24 Preliminary molecular docking studies using GOLD suite versions 4.1 and 5.0 
(CCDC, Cambridge, UK)25 indicated that the more potent derivatives 5 and 26, having small 
side chains, fitted “horizontally” in the active site while those with longer side chains (for 
example, 33) fitted only “vertically” into the active-site gorge (Figure 1). Further studies to 






Figure 1. Overlay of the alkyne 26 (yellow carbons, ‘horizontal’ binding near the active site 
at the base of the active site gorge) and the phenyl alkyne derivative 33 (green carbons, 
‘vertical’ binding, along the walls of the gorge) docked into the active site gorge of Torpedo 
californica AChE (TcAChE). The amino acid residues at the binding sites of TcAChE are 
coloured pink for the active site and blue for the PAS. This view is expanded in the lower 
figure. 
 
In conclusion, thirty two new stemofoline analogues were prepared to study as AChE 
inhibitors. In general the amine derivatives were found to be stronger inhibitors of AChE than 
their alcohol analogues that we previously reported.9,10 Three compounds (tertiary amine 4, 
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carbamate 22 and the terminal alkyne 26) were found to be as active as galanthamine using 
the TLC bioautographic method while Ellman’s assay, against eeAChE and human AChE 
(hAChE), identified didehydrostemofoline 1 and compound 5 as the most active of the 
compounds tested with IC50 values in the range of 12−25 µM against eeAChE and hAChE. 
These activities were significantly less than that of galanthamine.  
Experimental 
3.1 General experimental procedures. All reactions, unless otherwise stated, were 
performed in oven dried, single-necked round bottom flasks under an atmosphere of dry 
nitrogen. Reagents and analytical grade solvents were purchased from commercial sources. 
Progress of reactions was monitored by TLC using aluminium backed Merck F254 sorbent 
silica gel with UV detection at 254 nm and/or Dragendorff’s reagent. Compounds were 
purified by column chromatography using Merck flash silica gel (40 – 63 µm). Purity of 
compounds was determined by 1H NMR spectroscopy and HPLC (see supporting information 
for details), and was always ≥ 95%. 1H and 13C NMR spectra were recorded on a Varian 
Inova-500 spectrometer (500 MHz 1H, 125 MHz 13C) in deuterochlroform (CDCl3), unless 
otherwise specified. NMR assignments were based on gCOSY, gHSQC, gHMBC and DEPT 
or APT experiments. 1H and 13C NMR assignments are based on the numbering system used 
for stemofoline and not on the systematic name and numbering used in the naming of many 
stemofoline derivatives and analogues in the experimental section. Low resolution mass 
spectra were obtained on a Waters LCZ single quadropole (ESI). High-resolution mass 
spectra were obtained on a Waters QTOF (ESI). The microwave reactions were performed on 
a CEM Discovery Microwave Synthesis System (NC, USA). 
 
3.1.1 General reaction procedure and preparation of (5Z)-5-
[(2S,2aR,6S,7aS,7bR,8R,9S)-hexahydro-7b-1-(N-methylaminomethyl)-9-methyl-4H-
2,2,6-(epoxy[1]propanyl[3]ylidene)furo[2,3,4-gh]pyrrolizin-10-ylidene]-4-methoxy-3-
methyl-2(5H)-furanone (3). To a solution of aldehyde 2 (26.4 mg, 0.074 mmol) in dry 
dichloroethane (2.0 mL) and acetic acid (0.2 mL) at rt was added methylamine (8.03 M in 
MeOH, 16.3 µL, 0.147 mmol) and then NaBH(OAc)3 (46.7 mg, 0.220 mmol). The reaction 
mixture was left to stir for 24 h. The mixture was quenched with saturated aqueous NaHCO3 
solution (10 mL) and was directly extracted with CH2Cl2 (3 × 20 mL).  The combined 
organic extracts were washed with brine and dried (MgSO4) before being concentrated in 
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vacuo. The concentrated residue was purified by column chromatography using gradient 
elution from CH2Cl2 to CH2Cl2/MeOH (9:1) to give the amine 3 (13.8 mg, 0.037 mmol, 60% 
yield) as a yellow gum. Rf  = 0.10 in MeOH/CH2Cl2 (1:9). [α]
25
D  +311.1 (c 0.92, CHCl3). IR 
νmax 3350, 2941, 2921, 2880, 2794, 1756, 1623 cm
-1. 1H NMR δ 4.42 (s, 1H, H-2), 4.12 (s, 
3H, O-CH3), 3.44 (br s, 1H, H-9a), 3.12-3.07 (m, 2H, H-5a, H-10), 3.02-2.98 (m, 1H, H-5b), 
2.70 (s, 2H, H-1′), 2.67 (d, J 6.5 Hz, 1H, H-7), 2.45 (s, 3H, H-3′), 2.06 (s, 3H, H-16), 1.94 (d, 
J 12.0 Hz, 1H, H-1b), 1.92-1.87 (m, 1H, H-6a), 1.85-1.80 (m, 2H, H-6b, H-9), 1.70 (d, J 12.0 
Hz, 1H, H-1a), 1.58 (br s, 1H, NH), 1.36 (d, J 7.0 Hz, 3H, H-17). 13C NMR δ 169.8 (C-15), 
163.0 (C-13), 148.5 (C-12), 128.0 (C-11), 112.6 (C-8), 98.7 (C-14), 82.8 (C-3), 79.0 (C-2), 
61.3 (C-9a), 59.0 (O-CH3), 52.6 (C-1′), 49.8 (C-7), 48.0 (C-9), 47.8 (C-5), 37.2 (N-CH3), 
34.7 (C-10), 33.7 (C-1), 27.2 (C-6), 18.4 (C-17), 9.3 (C-16). ESIMS m/z 375.0 (100%) 




gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-2(5H)-furanone (4). Prepared using the 
general method described above, using the aldehyde 2 (16.6 mg, 0.046 mmol), 
dichloroethane (2.0 mL), acetic acid (0.2 mL), dimethylamine (2.0 M in THF, 47 µL, 0.092 
mmol) and NaBH(OAc)3 (29.4 mg, 0.139 mmol). The purified product was obtained as a 
yellow gum (7.0 mg, 0.018 mmol, 39% yield). Rf  = 0.26 in MeOH/CH2Cl2 (1:9). [α]
25
D  
+281.3 (c 0.47, CHCl3). IR νmax 2936, 2768, 2356, 2337, 1743, 1620 cm
-1. 1H NMR δ 4.38 (s, 
1H, H-2), 4.13 (s, 3H, O-CH3), 3.45 (br s, 1H, H-9a), 3.17-.311 (m, 1H, H-5a), 3.11-3.06 
(m,1H, H-10), 3.03-2.97 (m, 1H, H-5b), 2.78 (d, J 6.0 Hz, 1H, H-7), 2.48 (d, J 13.5 Hz, 1H, 
H-1′a), 2.35 (d, J 13.5 Hz, 1H, H-1′b), 2.30 (s, 6H, N-CH3), 2.06 (s, 3H, H-16), 1.95 (d, J 
11.5 Hz, 1H, H-1a), 1.91-1.86 (m, 1H, H-6a), 1.84-1.81 (m, 1H, H-6b), 1.79-1.76 (m, 1H, H-
9), 1.76-1.74 (m, 1H, H-1b), 1.36 (d, J 7.0 Hz, 3H, H-17). 13C NMR δ 169.8 (C-15), 163.0 
(C-13), 148.6 (C-12), 128.0 (C-11), 112.7 (C-8), 98.8 (C-14), 83.2 (C-3), 79.0 (C-2), 60.8 (C-
9a), 59.9 (C-1′), 59.0 (O-CH3), 49.7 (C-7), 47.9 (C-5, C-9), 47.3 (N-CH3), 34.7 (C-10), 33.3 
(C-1), 27.1 (C-6), 18.5 (C-17), 9.3 (C-16). ESIMS m/z 389.0 (100%) [M+H]+, 390.2 (20%). 






methoxy-3-methyl-2(5H)-furanone (5). Prepared using the general method described above, 
using the aldehyde 2 (24.3 mg, 0.068 mmol), dichloroethane (2.0 mL), acetic acid (0.2 mL), 
isopropylamine (11.6 µL, 0.135 mmol) and NaBH(OAc)3 (43.0 mg, 0.203 mmol). The 
purified product was obtained as a colourless gum (21.1 mg, 0.052 mmol, 78% yield). Rf  = 
0.23 in MeOH/CH2Cl2 (1:9). [α]
25
D  +246.9 (c 1.26, CHCl3). IR νmax 3383, 2961, 2885, 2356, 
2337, 1742, 1621 cm-1. 1H NMR δ 4.43 (br s, 1H, H-2), 4.13 (s, 3H, O-CH3), 3.45 (br s, 1H, 
H-9a), 3.12-3.06 (m, 2H, H-5, H-10), 3.02-2.97 (m, 1H, H-5), 2.77-2.74 (m, 1H, H-1′′), 2.74 
(d, J 10.0 Hz, 1H, H-1′), 2.69 (d, J 10.0 Hz, 1H, H-1′), 2.67 (d, J 5.0 Hz, 1H, H-7), 2.06 (s, 
3H, H-16), 1.94 (d, J 11.5 Hz, 1H, H-1a), 1.91-1.87 (m, 1H, H-9), 1.85-1.81 (m, 2H, H-6), 
1.71 (d, J 12.0 Hz, 1H, H-1b), 1.50 (br s, 1H, NH), 1.37 (d, J 7.0 Hz, 3H, H-17), 1.05 (d, J 
6.5 Hz, 3H, H-4′), 1.02 (d, J 6.0 Hz, 3H, H-2′′). 13C NMR δ 169.9 (C-15), 163.0 (C-13), 
148.6 (C-12), 128.0 (C-11), 112.6 (C-8), 98.7 (C-14), 82.9 (C-3), 79.1 (C-2), 61.3 (C-9a), 
59.0 (O-CH3), 49.9 (C-7), 49.4 (C-1′′), 48.0 (C-1′), 47.8 (C-5), 34.7 (C-10), 33.7 (C-1, C-9), 
27.2 (C-6), 23.4 (C-2′′), 22.8 (C-4′), 18.5 (C-17), 9.3 (C-16). ESIMS m/z 403.0 (100%) 




methoxy-3-methyl-2(5H)-furanone (6). Prepared using the general method described above, 
using the aldehyde 2 (24.0 mg, 0.067 mmol), dichloroethane (2.0 mL), acetic acid (0.2 mL), 
allylamine (10.0 µL, 0.134 mmol) and NaBH(OAc)3 (42.5 mg, 0.200 mmol). The purified 
product was obtained as a yellow gum (18.7 mg, 0.047 mmol, 70% yield). Rf  = 0.11 in 
MeOH/EtOAc (2:8). [α] 25D  +437.6 (c 1.25, CHCl3). IR νmax 3402, 2952, 2925, 28880, 2847, 
1742, 1619 cm-1. 1H NMR δ 5.89-5.81 (m, 1H, H-2′′), 5.15 (dd, J 16.0 Hz, 1.5 Hz, 1H, H-
3′′(E)), 5.08 (dd, J 10.0 Hz, 1.0 Hz, 1H, H-3′′(Z)), 4.44 (br s, 1H, H-2), 4.12 (s, 3H, O-CH3), 
3.44 (br s, 1H, H-9a), 3.29-3.22 (m, 2H, H-1′′), 3.11-3.06 (m, 2H, H-5b, H-10), 3.02-2.96 (m, 
1H, H-5a), 2.71 (ABq, J 10.0 Hz, 2H, H-1′), 2.66 (d, J 6.0 Hz, 1H, H-7), 2.05 (s, 3H, H-16), 
1.94 (d, J 12.0 Hz, 1H, H-1a), 1.90-1.86 (m, 1H, H-6b), 1.84-1.79 (m, 2H, H-6a, H-9), 1.71 
(dt, J 12.0 Hz, 3.0 Hz, 1H, H-1b), 1.63 (br s, 1H, NH), 1.36 (d, J 6.5 Hz, 3H, H-17). 13C 
NMR δ 169.8 (C-15), 163.0 (C-13), 148.5 (C-12), 136.9 (C-2′′), 128.0 (C-11), 116.1 (C-3′′), 
112.6 (C-8), 98.7 (C-14), 82.9 (C-3), 79.0 (C-2), 61.3 (C-9a), 59.0 (O-CH3), 52.8 (C-1′′), 49.8 
(C-7), 49.5 (C-1′), 48.0 (C-9), 47.8 (C-5), 34.6 (C-10), 33.7 (C-1), 27.2 (C-6), 18.4 (C-17), 
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9.3 (C-16). ESIMS m/z 401.0 (100%) [M+H]+, 402.1 (20%). HRESIMS m/z 401.2073 





2(5H)-furanone (7). Prepared using the general method described above, using the aldehyde 
2 (23.9 mg, 0.067 mmol), dichloroethane (2.0 mL), acetic acid (0.2 mL), 2-
(dimethylamino)ethylamine (15.3 µL, 0.133 mmol) and NaBH(OAc)3 (42.3 mg, 0.200 
mmol). The purified product was obtained as a colourless gum (8.2 mg, 0.019 mmol, 28% 
yield). Rf  = 0.17 in MeOH/CH2Cl2 (4:6). [α]
25
D  +178.5 (c 0.55, CHCl3). IR νmax 3384, 2962, 
2932, 2360, 1740, 1618 cm-1. 1H NMR (300 MHz) δ 4.43 (br s, 1H, H-2), 4.13 (s, 3H, O-
CH3), 3.46 (br s, 1H, H-9a), 3.16-3.06 (m, 2H, H-5, H-10), 3.04-2.95 (m, 1H, H-5), 2.75 (s, 
2H, H-1′), 2.74 (t, J 6.0 Hz, 2H, H-1′′), 2.69 (d, J 5.4 Hz, 1H, H-7), 2.44 (t, J 6.0 Hz, 2H, H-
2′′), 2.25 (s, 6H, N-CH3), 2.20 (br s, 1H, NH), 2.06 (s, 3H, H-16), 1.94 (d, J 12.0 Hz, 1H, H-
1a), 1.90-1.84 (m, 2H, H-6), 1.79 (dd, J 10.2 Hz, 3.6 Hz, 1H, H-9), 1.73 (dt, J 12.3 Hz, 3.3 
Hz, 1H, H-1b), 1.36 (d, J 6.6 Hz, 3H, H-17). 13C NMR (75 MHz) δ 169.9 (C-15), 163.0 (C-
13), 148.5 (C-12), 128.0 (C-11), 112.6 (C-8), 98.7 (C-14), 82.9 (C-3), 78.9 (C-2), 61.2 (C-
9a), 59.0 (O-CH3), 58.9 (C-2′′), 50.3 (C-1′), 49.8 (C-7), 48.3 (C-9), 47.9 (C-5, C-1′′), 45.6 (N-
CH3), 34.6 (C-10), 33.6 (C-1), 27.1 (C-6), 18.4 (C-17), 9.3 (C-16). ESIMS m/z 432.0 (100%) 




gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-2(5H)-furanone (8). Prepared using the 
general method described above, using the aldehyde 2 (18.6 mg, 0.052 mmol), 
dichloroethane (2.0 mL), acetic acid (0.2 mL), ethanolamine (8.5 µL, 0.104 mmol) and 
NaBH(OAc)3 (32.9 mg, 0.155 mmol). The purified product was obtained as a colourless gum 
(10.0 mg, 0.025 mmol, 48% yield). Rf  = 0.20 in MeOH/CH2Cl2 (1:9). [α]
25
D  +267.7 (c 0.67, 
CHCl3). IR νmax 3392, 2961, 2936, 1740, 1618, 1143 cm
-1. ESIMS m/z 405.0 (100%) 
[M+H]+, 406.1 (15%). HRESIMS m/z 405.2015 [M+H]+, calcd for C21H29N2O6 405.2026. 
1H 
NMR δ 4.42 (br s, 1H, H-2), 4.13 (s, 3H, O-CH3), 3.66-3.58 (m, 2H, H-2′′), 3.48 (br s, 1H, H-
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9a), 3.16-3.12 (m, 1H, H-5a), 3.11-3.06 (m, 1H, H-10), 3.04-2.99 (m, 1H, H-5b), 2.87-2.83 
(m, 1H, H-1′), 2.84 (d, J 12.0 Hz, 1H, H-1′′), 2.81-2.76 (m, 1H, H-1′), 2.76 (d, J 12.0 Hz, 1H, 
H-1′′), 2.67 (d, J 6.0 Hz, 1H, H-7), 2.11 (br s, 1H, NH), 2.06 (s, 3H, H-16), 1.96 (d, J 12.0 
Hz, 1H, H-1a), 1.94-1.88 (m, 1H, H-6a), 1.88-1.85 (m, 1H, H-6b), 1.84-1.81 (m, 1H, H-9), 
1.74 (d, J 12.0 Hz, 1H, H-1b), 1.37 (d, J 6.0 Hz, 3H, H-17). 13C NMR δ 169.9 (C-15), 163.0 
(C-13), 148.4 (C-12), 128.1 (C-11), 112.5 (C-8), 98.8 (C-14), 83.2 (C-3), 78.9 (C-2), 61.2 (C-
9a, C-2′′), 59.0 (O-CH3), 51.8 (C-1′′), 49.7 (C-7), 49.6 (C-1′), 48.0 (C-9), 47.8 (C-5), 34.6 (C-
10), 33.6 (C-1), 27.1 (C-6), 18.4 (C-17), 9.3 (C-16). ESIMS m/z 405.0 (100%) [M+H]+, 406.1 




methoxy-3-methyl-2(5H)-furanone (9). Prepared using the general method described above, 
using the aldehyde 2 (24.8 mg, 0.069 mmol), dichloroethane (2.0 mL), acetic acid (0.2 mL), 
morpholine (12.2 µL, 0.138 mmol) and NaBH(OAc)3 (43.9 mg, 0.207 mmol). The purified 
product was obtained as a colourless gum (18.7 mg, 0.043 mmol, 63% yield). Rf  = 0.28 in 
MeOH/CH2Cl2 (1:9). [α]
25
D  +317.6 (c 0.99, CHCl3). IR νmax 2951, 2932, 2359, 2337, 1740, 
1620 cm-1. 1H NMR δ 4.35 (br s, 1H, H-2), 4.13 (s, 3H, O-CH3), 3.69-3.63 (m, 4H, H-2′′), 
3.42 (br s, 1H, H-9a), 3.16-3.11 (m, 1H, H-5b), 3.09-3.05 (m, 1H, H-10), 3.01-2.96 (m, 1H, 
H-5a), 2.79 (br s, 2H, H-3′′), 2.75 (d, J 5.5 Hz, 1H, H-7), 2.49-2.43 (m, 2H, H-1′), 2.40-2.37 
(m, 2H, H-3′′), 2.06 (s, 3H, H-16), 1.94 (d, J 12.5 Hz, 1H, H-1a), 1.92-1.86 (m, 1H, H-6b), 
1.83-1.80 (m, 1H, H-6a), 1.79-1.75 (m, 1H, H-9), 1.71 (br s, 1H, H-1b), 1.36 (d, J 6.5 Hz, 
3H, H-17). 13C NMR δ 169.8 (C-15), 162.9 (C-13), 148.4 (C-12), 128.0 (C-11), 112.7 (C-8), 
98.7 (C-14), 83.2 (C-3), 79.0 (C-2), 67.2 (C-2′′), 60.8 (C-9a), 59.0 (O-CH3), 58.9 (C-1′), 55.2 
(C-3′′), 49.6 (C-7), 47.8 (C-5, C-9), 34.6 (C-10), 33.3 (C-1), 27.2 (C-6), 18.4 (C-17), 9.3 (C-
16). ESIMS m/z 431.2 (100%) [M+H]+, 432.3 (5%). HRESIMS m/z 431.2163 [M+H]+, calcd 




gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-2(5H)-furanone (10). Prepared using the 
general method described above, using the aldehyde 2 (26.6 mg, 0.074 mmol), 
dichloroethane (2.0 mL), acetic acid (0.2 mL), ethyl 1-piperazinecarboxylate (22.0 µL, 0.148 
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mmol) and NaBH(OAc)3 (47.1 mg, 0.222 mmol). The purified product was obtained as a 
colourless gum (28.9 mg, 0.058 mmol, 78% yield). Rf  = 0.33 in MeOH/CH2Cl2 (1:9). [α]
25
D  
+236.7 (c 1.93, CHCl3). IR νmax 2964, 2932, 2356, 2337, 1743, 1694, 1620 cm
-1. 1H NMR δ 
4.34 (br s, 1H, H-2), 4.12 (s, 3H, O-CH3), 4.11-4.08 (m, 2H, NCO2CH2CH3), 3.42 (br s, 5H, 
H-9a, H-3′′), 3.14-3.04 (m, 2H, H-5a, H-10), 3.00-2.95 (m, 1H, H-5b), 2.76 (br s, 2H, H-2′′), 
2.72 (d, J 6.0 Hz, 1H, H-7), 2.46 (s, 2H, H-1′), 2.34-2.32 (m, 2H, H-2′′), 2.05 (s, 3H, H-16), 
1.93 (d, J 12.0 Hz, 1H, H-1a), 1.89-1.84 (m, 1H, H-6a), 1.82-1.78 (m, 1H, H-6b), 1.75 (dd, J 
10.0 Hz, 2.5 Hz, 1H, H-9), 1.69 (d, J 12.0 Hz, 1H, H-1b), 1.35 (d, J 7.0 Hz, 3H, H-17), 1.23 
(t, J 7.5 Hz, 3H, NCO2CH2CH3). 
13C NMR δ 169.8 (C-15), 162.9 (C-13), 155.6 
(NCO2CH2CH3), 148.4 (C-12), 128.0 (C-11), 112.7 (C-8), 98.6 (C-14), 83.2 (C-3), 79.0 (C-
2), 61.4 (NCO2CH2CH3), 60.8 (C-9a), 59.0 (O-CH3), 58.5 (C-1′), 54.4 (C-2′′), 49.7 (C-7), 
47.8 (C-5, C-9), 44.0 (C-3′′), 34.6 (C-10), 33.3 (C-1), 27.2 (C-6), 18.4 (C-17), 14.8 
(NCO2CH2CH3), 9.3 (C-16). ESIMS m/z 502.0 (100%) [M+H]
+, 503.1 (20%). HRESIMS m/z 




gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-2(5H)-furanone (11). Prepared using the 
general method described above, using the aldehyde 2 (26.0 mg, 0.072 mmol), 
dichloroethane (2.0 mL), acetic acid (0.2 mL), 1-methylpiperazine (16.2 µL, 0.145 mmol) 
and NaBH(OAc)3 (46.0 mg, 0.217 mmol). The purified product was obtained as a colourless 
gum (20.7 mg, 0.047 mmol, 64% yield). Rf  = 0.09 in MeOH/CH2Cl2 (1:9). [α]
25
D  +279.4 (c 
1.38, CHCl3). IR νmax 2961, 2939, 2356, 2325, 1742, 1618 cm
-1. 1H NMR δ 4.42 (br s, 1H, H-
2), 4.12 (s, 3H, O-CH3), 3.41 (br s, 1H, H-9a), 3.16-3.10 (m, 1H, H-5a), 3.08-3.04 (m, 1H, H-
10), 3.00-2.94 (m, 1H, H-5b), 2.80 (br s, 4H, H-2′′), 2.75 (d, J 6.0 Hz, 1H, H-7), 2.46 (s, 2H, 
H-1′), 2.42 (br s, 4H, H-3′′), 2.26 (s, 3H, N-CH3), 2.05 (s, 3H, H-16), 1.92 (d, J 12.0 Hz, 1H, 
H-1a), 1.89-1.85 (m, 1H, H-6a), 1.81-1.77 (m, 1H, H-6b), 1.75 (dd, J 9.0 Hz, 2.5 Hz, 1H, H-
9), 1.70 (d, J 12.0 Hz, 1H, H-1b), 1.35 (d, J 6.5 Hz, 3H, H-17). 13C NMR δ 169.8 (C-15), 
162.9 (C-13), 148.5 (C-12), 128.0 (C-11), 112.8 (C-8), 98.6 (C-14), 83.2 (C-3), 79.0 (C-2), 
60.8 (C-9a), 59.0 (O-CH3), 58.4 (C-1′), 55.4 (C-3′′), 54.5 (C-2′′), 49.5 (C-7), 47.9 (C-5), 47.8 
(C-9), 46.0 (N-CH3), 34.6 (C-10), 33.2 (C-1), 27.2 (C-6), 18.4 (C-17), 9.3 (C-16). ESIMS m/z 







methyl-2(5H)-furanone (12). Prepared using the general method described above, using the 
aldehyde 2 (15.9 mg, 0.044 mmol), dichloroethane (2.0 mL), acetic acid (0.2 mL), aniline 
(13.2 µL, 0.089 mmol) and NaBH(OAc)3 (28.2 mg, 0.133 mmol). The purified product was 
obtained as a colourless gum (3.0 mg, 0.007 mmol, 25% yield). Rf  = 0.74 in MeOH/CH2Cl2 
(1:9). [α] 25D  +272.1 (c 0.51, CHCl3). IR νmax 3380, 2964, 2923, 2363, 2331, 1742, 1621 cm
-1. 
1H NMR δ 7.18 (t, J 7.5 Hz, 2H, ArH), 6.73 (t, J 7.5 Hz, 1H, ArH), 6.66 (d, J 7.5 Hz, 2H, 
ArH), 4.42 (s, 1H, H-2), 4.14 (s, 3H, O-CH3), 3.62 (br s, 1H, H-9a), 3.45 (d, J 10.5 Hz, 1H, 
H-1′), 3.19-3.16 (m, 2H, H-5a, H-1′), 3.14-3.10 (m, 2H, H-5b, H-10), 2.84 (d, J 6.0 Hz, 1H, 
H-7), 2.07 (s, 3H, H-16), 2.02 (d, J 12.5 Hz, 1H, H-1a), 2.05-1.98 (m, 1H, H-6a), 1.94-1.90 
(m, 1H, H-6b), 1.89 (d, J 3.5 Hz, 1H, H-9), 1.86-1.84 (m, 1H, H-1b), 1.40 (d, J 7.0 Hz, 3H, 
H-17). 13C NMR δ 169.8 (C-15), 162.8 (C-13), 148.2 (C-12, ArC-N), 129.4 (ArCH), 128.2 
(C-11), 118.2 (ArCH), 113.4 (ArCH), 112.4 (C-8), 98.9 (C-14), 83.1 (C-3), 79.0 (C-2), 61.7 
(C-9a), 59.0 (O-CH3), 49.9 (C-7), 48.0 (C-9), 47.8 (C-5), 44.2 (C-1′), 34.6 (C-10), 33.7 (C-1), 
26.9 (C-6), 18.5 (C-17), 9.3 (C-16). ESIMS m/z 437.0 (100%) [M+H]+, 438.1 (20%). 




methoxy-3-methyl-2(5H)-furanone (13). Prepared using the general method described 
above, using the aldehyde 2 (26.0 mg, 0.072 mmol), dichloroethane (2.0 mL), acetic acid (0.2 
mL), N-benzylamine (16.0 µL, 0.145 mmol) and NaBH(OAc)3 (46.0 mg, 0.217 mmol). The 
purified product was obtained as a yellow gum (27.9 mg, 0.062 mmol, 86% yield). Rf  = 0.46 
in MeOH/CH2Cl2 (1:9). [α]
25
D  +196.9 (c 1.86, CHCl3). IR νmax 3388, 2958, 2945, 2356, 2337, 
1736, 1625 cm-1. 1H NMR (300 MHz) δ 7.34-7.29 (m, 4H, ArH), 7.25-7.23 (m, 1H, ArH), 
4.43 (br s, 1H, H-2), 4.13 (s, 3H, O-CH3), 3.82 (s, 2H, H-1′′), 3.45 (br s, 1H, H-9a), 3.11-3.08 
(m, 1H, H-10), 3.06-2.95 (m 2H, H-5), 2.74 (q, J 12.0 Hz, 1H, H-1′), 2.69 (d, J 12.0 Hz, 1H, 
H-1′), 2.65 (d, J 6.0 Hz, 1H, H-7), 2.06 (s, 3H, H-16), 1.95 (d, J 12.0 Hz, 1H, H-1a), 1.82-
1.79 (m, 3H, H-6, H-9), 1.74 (dt, J 12.0 Hz, 3.0 Hz, 1H, H-1b), 1.37 (d, J 6.0 Hz, 3H, H-17). 
13C NMR (75 MHz, one ArCH was not observed due to peak overlap) δ 169.8 (C-15), 163.0 
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(C-13), 148.5 (C-12), 140.4 (ArC), 128.5 (ArCH), 128.0 (C-11), 127.0 (ArCH), 112.6 (C-8), 
98.6 (C-14), 82.9 (C-3), 79.1 (C-2), 61.3 (C-9a), 59.0 (O-CH3), 54.1 (C-1′′), 49.7 (C-7), 49.2 
(C-1′), 48.0 (C-9), 47.8 (C-5), 34.6 (C-10), 33.7 (C-1), 27.2 (C-6), 18.4 (C-17), 9.2 (C-16). 






2(5H)-furanone (14). Prepared using the general method described above, using the 
aldehyde 2 (24.8 mg, 0.069 mmol), dichloroethane (2.0 mL), acetic acid (0.2 mL), 
(aminomethyl)cyclopropane (12.4 µL, 0.138 mmol) and NaBH(OAc)3 (43.9 mg, 0.207 
mmol). The purified product was obtained as a colourless gum (17.3 mg, 0.042 mmol, 60% 
yield). Rf  = 0.28 in MeOH/CH2Cl2 (1:9). [α]
25
D  +276.5 (c 1.15, CHCl3). IR νmax 3347, 2999, 
2951, 2359, 2337, 1742, 1619 cm-1. 1H NMR δ 4.45 (br s, 1H, H-2), 4.12 (s, 3H, O-CH3), 
3.46 (br s, 1H, H-9a), 3.12-3.06 (m, 2H, H-5b, H-10), 3.02-2.97 (m, 1H, H-5a), 2.77 (s, 2H, 
H-1′), 2.68 (d, J 6.0 Hz, 1H, H-7), 2.54 (dd, J 12.5 Hz, 6.5 Hz, 1H, H-1′′a), 2.44 (dd, J 12.5 
Hz, 6.5 Hz, 1H, H-1′′b), 2.05 (s, 3H, H-16), 1.99 (br s, 1H, NH), 1.94 (d, J 12.5 Hz, 1H, H-
1a), 1.91-1.86 (m, 1H, H-6a), 1.84-1.79 (m, 2H, H-6b, H-9), 1.73 (dt, J 12.5 Hz, 3.5 Hz, 1H, 
H-1b), 1.36 (d, J 6.5 Hz, 3H, H-17), 0.96-0.89 (m, 1H, H-2′′), 0.46-0.45 (m, 2H, H-3′′), 0.10-
0.08 (m, 2H, H-3′′). 13C NMR δ 169.8 (C-15), 163.0 (C-13), 148.5 (C-12), 128.0 (C-11), 
112.6 (C-8), 98.7 (C-14), 83.9 (C-3), 79.0 (C-2), 61.3 (C-9a), 59.0 (O-CH3), 55.5 (C-1′′), 49.9 
(C-1′), 49.8 (C-7), 48.0 (C-9), 47.8 (C-5), 34.6 (C-10), 33.7 (C-1), 27.2 (C-6), 18.4 (C-17), 
11.1 (C-2′′), 9.3 (C-16), 3.6 (C-3′′), 3.4 (C-3′′). ESIMS m/z 415.1 (100%) [M+H]+, 416.2 




gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-2(5H)-furanone (15). Prepared using the 
general method described above, using the aldehyde 2 (21.6 mg, 0.060 mmol), 
dichloroethane (2.0 mL), acetic acid (0.2 mL), cyclopropylamine (8.2 µL, 0.120 mmol) and 
NaBH(OAc)3 (38.3 mg, 0.181 mmol). The purified product was obtained as a yellow gum 
(22.4 mg, 0.056 mmol, 93% yield). Rf  = 0.36 in MeOH/CHCl3 (1:9). [α]
25
D  +281.4 (c 0.25, 
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CHCl3). IR νmax 3364, 2961, 2936, 2356, 2334, 1742, 1620 cm
-1. 1H NMR δ 4.42 (br s, 1H, 
H-2), 4.07 (s, 3H, O-CH3), 3.42 (br s, 1H, H-9a), 3.10-3.01 (m, 2H, H-5a, H-10), 2.99-2.93 
(m, 1H, H-5b), 2.81 (d, J 12.0 Hz, 1H, H-1′), 2.75 (d, J 12.0 Hz, 1H, H-1′), 2.63 (d, J 6.0 Hz, 
1H, H-7), 2.03 (apparent sept, J 3.0 Hz, 1H, H-1′′), 2.00 (s, 3H, H-16), 1.89-1.83 (m, 1H, H-
6b), 1.86 (d, J 12.0 Hz, 1H, H-1a), 1.80-1.74 (m, 2H, H-6b, H-9), 1.63 (d, J 12.0 Hz, 1H, H-
1b), 1.30 (d, J 6.5 Hz, 3H, H-17), 0.36 (d, J 6.5 Hz, 2H, H-2′′), 0.29-0.26 (m, 1H, H-2′′), 
0.23-0.21 (m, 1H, H-2′′). 13C NMR δ 169.9 (C-15), 163.0 (C-13), 148.5 (C-12), 128.0 (C-11), 
112.5 (C-8), 98.6 (C-14), 82.9 (C-3), 78.9 (C-2), 61.2 (C-9a), 59.0 (O-CH3), 49.7 (C-1′), 49.6 
(C-7), 47.9 (C-9), 47.8 (C-5), 34.6 (C-10), 33.5 (C-1), 31.0 (C-1′′), 27.0 (C-6), 18.4 (C-17), 
9.2 (C-16), 6.4 (C-2′′). ESIMS m/z 400.7 (100%) [M+H]+, 401.9 (25%). HRESIMS m/z 




gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-2(5H)-furanone (16). Prepared using the 
general method described above, using the aldehyde 2 (22.6 mg, 0.063 mmol), 
dichloroethane (2.0 mL), acetic acid (0.2 mL), cyclopentylamine (12.9 µL, 0.126 mmol) and 
NaBH(OAc)3 (40.0 mg, 0.189 mmol). The purified product was obtained as a yellow gum 
(24.4 mg, 0.057 mmol, 90% yield). Rf  = 0.21 in MeOH/CHCl3 (1:9). [α]
25
D  +206.6 (c 0.35, 
CHCl3). IR νmax 3351, 2951, 2885, 2359, 2337, 1743, 1620 cm
-1. 1H NMR δ 4.38 (br s, 1H, 
H-2), 4.07 (s, 3H, O-CH3), 3.39 (br s, 1H, H-9a), 3.06-3.00 (m, 2H, H-5, H-10), 2.98-2.94 (m, 
2H, H-5, H-1′′), 2.67 (s, 2H, H-1′), 2.61 (d, J 6.0 Hz, 1H, H-7), 2.18 (br s, 1H, NH), 1.99 (s, 
3H, H-16), 1.87 (d, J 12.0 Hz, 1H, H-1a), 1.84-1.81 (m, 1H, H-6a), 1.76-1.74 (m, 3H, H-6b, 
H-2′′), 1.65 (d, J 12.0 Hz, 1H, H-1b), 1.60-1.56 (m, 2H, H-3′′), 1.48-1.44 (m, 2H, H-3′′), 1.30 
(d, J 6.5 Hz, 3H, H-17), 1.28-1.21 (m, 2H, H-2′′). 13C NMR δ 169.8 (C-15), 162.9 (C-13), 
148.5 (C-12), 127.9 (C-11), 112.5 (C-8), 98.5 (C-14), 82.8 (C-3), 79.0 (C-2), 61.2 (C-9a), 
60.2 (C-1′′), 58.9 (O-CH3), 49.7 (C-7), 48.7 (C-1′), 47.9 (C-9), 47.7 (C-5), 34.6 (C-10), 33.6 
(C-1), 33.1 (C-2′′), 33.0 (C-2′′), 27.1 (C-6), 24.1 (C-3′′), 24.0 (C-3′′), 18.4 (C-17), 9.2 (C-16). 







methoxy-3-methyl-2(5H)-furanone (17). Prepared using the general method described 
above, using the aldehyde 2 (23.2 mg, 0.065 mmol), dichloroethane (2.0 mL), acetic acid (0.2 
mL), cyclohexylamine (15.0 µL, 0.129 mmol) and NaBH(OAc)3 (41.1 mg, 0.194 mmol). The 
purified product was obtained as a yellow gum (24.6 mg, 0.056 mmol, 86% yield). Rf  = 0.30 
in MeOH/CHCl3 (1:9). [α]
25
D  +250.9 (c 1.05, CHCl3). IR νmax 3377, 2929, 2856, 2363, 2337, 
1743, 1621 cm-1. 1H NMR δ 4.43 (br s, 1H, H-2), 4.12 (s, 3H, O-CH3), 3.45 (br s, 1H, H-9a), 
3.11-3.06 (m, 2H, H-5b, H-10), 3.02-2.96 (m, 1H, H-5a), 2.79 (d, J 12.0 Hz, 1H, H-1′), 2.72 
(d, J 12.0 Hz, 1H, H-1′), 2.67 (d, J 6.0 Hz, 1H, H-7), 2.42-2.38 (m, 1H, H-1′′), 2.06 (s, 3H, H-
16), 1.93 (d, J 11.5 Hz, 1H, H-1a), 1.90-1.87 (m, 1H, H-6b), 1.84-1.80 (m, 4H, H-6a, H-9, H-
2′′), 1.73-1.69 (m, 3H, H-1b, H-3′′), 1.58 (d, J 12.0 Hz, 1H, H-4′′), 1.36 (d, J 6.0 Hz, 3H, H-
17), 1.28-1.21 (m, 2H, H-3′′), 1.18-1.11 (m, 1H, H-4′′), 1.09-1.04 (m, 2H, H-2′′). 13C NMR δ 
169.8 (C-15), 163.0 (C-13), 148.5 (C-12), 128.0 (C-11), 112.6 (C-8), 98.7 (C-14), 83.0 (C-3), 
79.1 (C-2), 61.3 (C-9a), 59.0 (O-CH3), 57.5 (C-1′′), 49.8 (C-7), 48.1 (C-9), 47.8 (C-5), 47.3 
(C-1′), 34.6 (C-10), 33.7 (C-2′′), 33.6 (C-1), 33.3 (C-2′′), 27.2 (C-6), 26.3 (C-4′′), 25.1 (C-3′′), 
25.0 (C-3′′), 18.4 (C-17), 9.3 (C-16). ESIMS m/z 443.0 (100%) [M+H]+. HRESIMS m/z 





Prepared using the general method described above, using the aldehyde 2 (29.7 mg, 0.083 
mmol), dichloroethane (2.0 mL), acetic acid (0.2 mL), (S)-1-aminoethylbenzene (21.3 µL, 
0.165 mmol) and NaBH(OAc)3 (105.2 mg, 0.496 mmol). The purified product was obtained 
as a yellow gum (31.1 mg, 0.067 mmol, 81% yield). Rf  = 0.38 in MeOH/CHCl3 (1:9). [α]
25
D  
+166.0 (c 2.07, CHCl3). IR νmax 3015, 2958, 2359, 2334, 1742, 1621 cm
-1. 1H NMR δ 7.34-
7.30 (m, 2H, ArH), 7.26 (s, 2H, ArH), 7.25-7.20 (m, 1H, ArH), 4.45 (br s, 1H, H-2), 4.13 (s, 
3H, O-CH3), 3.71 (d, J 6.0 Hz, 1H, H-1′′a), 3.44 (br s, 1H, H-9a), 3.09 (br s, 1H, H-10), 2.93 
(br s, 2H, H-5), 2.64 (d, J 12.0 Hz, 1H, H-1′), 2.62 (d, J 6.0 Hz, 1H, H-7), 2.53 (d, J 12.0 Hz, 
1H, H-1′), 2.06 (s, 3H, H-16), 1.98-1.93 (m, 1H, H-1a), 1.80-1.72 (m, 4H, H-1b, H-6a,b, H-
9), 1.36 (d, J 6.0 Hz, 3H, H-17), 1.33 (d, J 6.0 Hz, 3H, 1′′-CH3). 
13C NMR δ 169.8 (C-15), 
162.9 (C-13), 148.5 (C-12), 145.9 (ArC), 128.5 (ArCH), 127.9 (C-11), 126.9 (ArCH), 126.4 
(ArCH), 112.5 (C-8), 98.6 (C-14), 82.8 (C-3), 79.1 (C-2), 61.2 (C-9a), 59.0 (O-CH3), 58.5 
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(C-1′′), 49.6 (C-7), 47.8 (C-5, C-9, C-1′), 34.6 (C-10), 33.6 (C-1), 27.1 (C-6), 24.3 (1′′-CH3), 
18.4 (C-17), 9.2 (C-16). ESIMS m/z 464.6 (100%) [M+H]+, 465.2 (25%). HRESIMS m/z 




gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-2(5H)-furanone (19). Prepared using the 
general method described above, using the aldehyde 2 (30.9 mg, 0.086 mmol), 
dichloroethane (2.0 mL), acetic acid (0.2 mL), (R)-1-aminoethylbenzene (21.0 µL, 0.172 
mmol) and NaBH(OAc)3 (109.5 mg, 0.517 mmol). The purified product was obtained as a 
yellow gum (24.7 mg, 0.053 mmol, 62% yield). Rf  = 0.41 in MeOH/CHCl3 (1:9). [α]
25
D  
+100.9 (c 1.65, CHCl3). IR νmax 3030, 2961, 2936, 2356, 2340, 1742, 1620 cm
-1. 1H NMR δ 
7.34-7.28 (m, 2H, H-6′), 7.30 (d, J 2.5 Hz, 2H, ArH), 7.24-7.20 (m, 1H, ArH), 4.38 (br s, 1H, 
H-2), 4.12 (s, 3H, O-CH3), 3.74 (q, J 6.5 Hz, 1H, H-1′′b), 3.46 (br s, 1H, H-9a), 3.10-3.04 (m, 
2H, H-5, H-10), 3.00-2.95 (m, 1H, H-5), 2.62 (d, J 12.0 Hz, 1H, H-1′), 2.55 (d, J 4.5 Hz, 1H, 
H-7), 2.46 (d, J 12.0 Hz, 1H, H-1′), 2.04 (s, 3H, H-16), 1.95 (d, J 13.0 Hz, 1H, H-1a), 1.79-
1.77 (m, 4H, H-1b, H-6, H-9), 1.36 (d, J 6.5 Hz, 3H, H-17), 1.31 (d, J 6.5 Hz, 3H, 1′′-CH3). 
13C NMR δ 170.0 (C-15), 163.1 (C-13), 148.7 (C-12), 145.9 (ArC), 128.8 (ArCH), 128.0 (C-
11), 127.2 (ArCH), 126.8 (ArCH), 112.7 (C-8), 98.7 (C-14), 83.1 (C-3), 79.1 (C-2), 61.3 (C-
9a), 59.1 (O-CH3), 59.0 (C-1′′), 49.8 (C-7), 48.1 (C-9, C-1′), 47.9 (C-5), 34.8 (C-10), 33.8 (C-
1), 27.2 (C-6), 25.2 (1′′-CH3), 18.5 (C-17), 9.4 (C-16). ESIMS m/z 464.8 (100%) [M+H]
+, 
465.9 (25%). HRESIMS m/z 465.2390 [M+H]+, calcd for C27H33N2O5 465.2389. 
 
3.1.18 Methylation reaction: Preparation of (5Z)-5-[(2S,2aR,6S,7aS,7bR,8R,9S)-
hexahydro-7b-1-(N-methyl-N-allylaminomethyl)-9-methyl-4H-2,2,6-
(epoxy[1]propanyl[3]ylidene)furo[2,3,4-gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-
2(5H)-furanone (20). Prepared using the general method described above, using 
formaldehyde solution (ca. 400g/L, 3.75 µL, 0.245 mmol) as the aldehyde component, 
dichloroethane (2.0 mL), acetic acid (0.2 mL), the amine 6 (9.8 mg, 0.024 mmol) as the 
amine component and NaBH(OAc)3 (31.2 mg, 0.147 mmol). The reaction was left for 16 h. 
The purified product was obtained as a yellow gum (9.5 mg, 0.023 mmol, 94% yield). Rf  = 
0.37 in MeOH/CH2Cl2 (1:9). [α]
25
D  +263.6 (c 0.63, CHCl3). IR νmax 2955, 2920, 2847, 2359, 
1743, 1621 cm-1. 1H NMR (300 MHz) δ 5.89-5.75 (m, 1H, H-2′′), 5.15 (d, J 17.0 Hz, 1H, H-
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3′′(E)), 5.10 (d, J 9.0 Hz, 1H, H-3′′(Z)), 4.38 (br s, 1H, H-2), 4.13 (s, 3H, O-CH3), 3.44 (br s, 
1H, H-9a), 3.23 (dd, J 13.8 Hz, 6.3 Hz, 1H, H-1′′b), 3.18-3.14 (m, 1H, H-5a), 3.13-3.06 (m, 
1H, H-10), 3.03-2.98 (m, 1H, H-5b), 2.92 (dd, J 13.8 Hz, 6.6 Hz, 1H, H-1′′a), 2.76 (d, J 5.7 
Hz, 1H, H-7), 2.53 (d, J 13.8 Hz, 1H, H-1′), 2.42 (d, J 13.8 Hz, 1H, H-1′), 2.30 (s, 3H, N-
CH3), 2.06 (s, 3H, H-16), 1.94 (d, J 12.0 Hz, 1H, H-1a), 1.91-1.81 (m, 2H, H-6), 1.79-1.72 
(m, 2H, H-1b, H-9), 1.36 (d, J 6.6 Hz, 3H, H-17). 13C NMR (75 MHz) δ 169.9 (C-15), 163.0 
(C-13), 148.6 (C-12), 136.0 (C-2′′), 128.0 (C-11), 117.6 (C-3′′), 112.8 (C-8), 98.7 (C-14), 
83.4 (C-3), 79.0 (C-2), 62.4 (C-1′′), 60.8 (C-9a), 59.0 (O-CH3), 56.9 (C-1′), 49.7 (C-7), 47.9 
(C-5, C-9), 44.2 (N-CH3), 34.7 (C-10), 33.3 (C-1), 27.1 (C-6), 18.5 (C-17), 9.3 (C-16). 
ESIMS m/z 415.2 (100%) [M+H]+, 416.3 (10%). HRESIMS m/z 415.2220 [M+H]+, calcd for 
C23H31N2O5 415.2233. 
3.1.19 Carbamylation reaction: Preparation of (5Z)-5-[(2S,2aR,6S,7aS,7bR,8R,9S)-
Hexahydro-7b-1-(N-ethoxycarboxyl-N-cyclopropylaminomethyl)-9-methyl-4H-2,2,6-
(epoxy[1]propanyl[3]ylidene)furo[2,3,4-gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-
2(5H)-furanone (21). To a solution of the amine 15 (11.2 mg, 0.028 mmol) in THF/saturated 
aqueous NaHCO3 solution (2:1) (3.0 mL) at 0 °C was added ethyl chloroformate (4.5 µL, 
0.056 mmol) and the reaction was left to stir for 3 h. The mixture was quenched with 
saturated aqueous NaHCO3 solution (10 mL) and was directly extracted with CH2Cl2 (3 × 20 
mL). The combined organic extracts were washed with brine and dried (MgSO4) before being 
concentrated in vacuo. The concentrated residue was purified by column chromatography 
using gradient elution from CH2Cl2 to CH2Cl2/MeOH (9:1) to give 21 as a colourless gum 
(10.0 mg, 0.021 mmol, 76% yield). Rf  = 0.45 in MeOH/CHCl3 (1:9). [α]
25
D  +164.0 (c 0.91, 
CHCl3). IR νmax 2961, 2932, 2359, 1744, 1690, 1621 cm
-1. 1H NMR δ 4.63 (br s, 1H, H-2), 
4.16 (q, J 7.5 Hz, 2H, NCO2CH2CH3), 4.13 (s, 3H, O-CH3), 3.62 (d, J 13.0 Hz, 1H, H-1′), 
3.44 (br s, 1H, H-9a), 3.29 (d, J 13.0 Hz, 1H, H-1′), 3.28-3.22 (m, 1H, H-5a), 3.10-2.99 (m, 
2H, H-5b, H-10), 2.77 (d, J 6.0 Hz, 1H, H-7), 2.64 (br s, 1H, H-1′′), 2.10-2.02 (m, 1H, H-6a), 
2.05 (s, 3H, H-16), 1.94 (d, J 12.0 Hz, 1H, H-1a), 1.84-1.80 (m, 2H, H-6b, H-9), 1.72 (d, J 
12.0 Hz, 1H, H-1b), 1.36 (d, J 6.5 Hz, 3H, H-17), 1.26 (t, J 7.5 Hz, 3H, NCO2CH2CH3), 0.88-
0.82 (m, 1H, H-2′′), 0.78-0.74 (m, 1H, H-2′′), 0.74-0.67 (m, 1H, H-2′′), 0.65-0.56 (m, 1H, H-
2′′). 13C NMR (the carbamate C=O signal was not observed) δ 169.7 (C-15), 162.9 (C-13), 
148.3 (C-12), 128.1 (C-11), 112.5 (C-8), 98.8 (C-14), 83.5 (C-3), 78.2 (C-2), 60.7 (C-9a), 
61.7 (NCO2CH2CH3), 59.0 (O-CH3), 49.1 (C-7), 48.2 (C-5), 47.7 (C-9), 47.0 (C-1′), 34.6 (C-
10), 33.0 (C-1), 29.3 (C-1′′), 27.1 (C-6), 18.4 (C-17), 14.7 (NCO2CH2CH3), 10.0 (C-2′′), 9.3 
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(C-16), 8.8 (C-2′′). ESIMS m/z 472.6 (100%) [M+H]+, 473.7 (10%). HRESIMS m/z 473.2300 




gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-2(5H)-furanone (22). Prepared using the 
general method described above, using the amine 16 (11.2 mg, 0.026 mmol) 2:1 
THF/saturated aqueous NaHCO3 solution (3.0 mL) and ethyl chloroformate (5.0 µL, 0.052 
mmol). The purified product was obtained as a yellow gum (7.3 mg, 0.015 mmol, 56% yield).  
Rf  = 0.45 in MeOH/CHCl3 (1:9). [α]
25
D  +205.6 (c 0.61, CHCl3). IR νmax 2958, 2888, 2362, 
2337, 1737, 1675, 1616 cm-1. 1H NMR δ 4.50 (br s, 1H, H-2), 4.18-4.10 (m, 2H, 
NCO2CH2CH3), 4.13 (s, 3H, O-CH3), 3.70-3.63 (m, 2H, H-1′, H-1′′), 3.46 (br s, 1H, H-9a), 
3.24 (d, J 15.5 Hz, 1H, H-1′), 3.22-3.16 (m, 1H, H-5), 3.09-3.00 (m, 2H, H-5, H-10), 2.82 (d, 
J 5.5 Hz, 1H, H-7), 2.10-2.02 (m, 1H, H-6a), 2.06 (s, 3H, H-16), 1.93 (d, J 11.5 Hz, 1H, H-
1a), 1.84-1.72 (m, 7H, H-1b, H-6b, H-9, H-2′′), 1.48 (br s, 4H, H-3′′), 1.36 (d, J 6.0 Hz, 3H, 
H-16), 1.26 (t, J 6.0 Hz, 3H, NCO2CH2CH3). 
13C NMR (the carbamate C=O signal was not 
observed) δ 169.8 (C-15), 162.9 (C-13), 148.4 (C-12), 128.0 (C-11), 112.6 (C-8), 98.8 (C-
14), 83.7 (C-3), 77.6 (C-2), 62.6 (C-1′′), 61.4 (NCO2CH2CH3), 60.9 (C-9a), 59.0 (O-CH3), 
49.4 (C-7, C-1′), 48.2 (C-5), 47.8 (C-9), 34.7 (C-10), 33.0 (C-1), 27.1 (C-6), 24.9 (C-2′′), 24.8 
(C-3′′), 18.4 (C-17), 14.8 (NCO2CH2CH3), 9.3 (C-16). ESIMS m/z 500.7 (100%) [M+H]
+, 




gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-2(5H)-furanone (23). Prepared using the 
general method described above, using the the amine 17 (11.1 mg, 0.025 mmol), 2:1 
THF/saturated aqueous NaHCO3 solution (3.0 mL) and ethyl chloroformate (4.0 µL, 0.050 
mmol). The purified product was obtained as a yellow gum (10.2 mg, 0.020 mmol, 80% 
yield). Rf  = 0.45 in MeOH/CHCl3 (1:9). [α]
25
D  +192.6 (c 0.78, CHCl3). IR νmax 2929, 2366, 
1744, 1684, 1621 cm-1. 1H NMR δ 4.50 (br s, 1H, H-2), 4.18-4.10 (m, 2H, NCO2CH2CH3), 
4.13 (s, 3H, O-CH3), 3.64 (br s, 1H, H-1′), 3.46 (br s, 1H, H-9a), 3.41 (s, 1H, H-1′′), 3.20 (d, J 
15.0 Hz, 1H, H-5), 3.12-3.01 (m, 2H, H-5, H-10), 2.82 (d, J 6.0 Hz, 1H, H-7), 2.07 (s, 3H, H-
16), 1.94 (d, J 12.5 Hz, 1H, H-1a), 1.87-1.72 (m, 11H, H-1b, H-6, H-9, H-3′′, H-4′′), 1.61 
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(apparent d, J 9.0 Hz, 1H, H-2′′), 1.37 (d, J 6.5 Hz, 3H, H-17), 1.27 (t, J 7.0 Hz, 3H, 
NCO2CH2CH3), 1.22 (apparent d, J 13.0 Hz, 2H, H-3′′), 1.14-1.08 (m, 1H, H-2′′). 
13C NMR 
(the carbamate C=O signal was not observed) δ 169.8 (C-15), 162.9 (C-13), 148.4 (C-12), 
128.0 (C-11), 112.7 (C-8), 98.8 (C-14), 83.7 (C-3), 77.6 (C-2), 70.8 (C-1′′), 61.4 (C-9a), 61.2 
(NCO2CH2CH3), 59.0 (O-CH3), 48.5 (C-1′), 48.2 (C-5, C-7), 47.8 (C-9), 34.7 (C-10), 33.0 
(C-1), 27.2 (C-4′′), 26.6 (C-6, C-3′′), 25.6 (C-2′′), 18.4 (C-17), 14.8 (NCO2CH2CH3), 9.3 (C-
16). ESIMS m/z 514.5 (100%) [M+H]+, 515.3 (40%). HRESIMS m/z 515.2726 [M+H]+, 
calcd for C28H39N2O7 515.2757. 
 




2(5H)-furanone (24). To a solution of the amine 3 (8.8 mg, 0.024 mmol) in dry CH2Cl2 (2.0 
mL) was added 1,3-di-Boc-2-(trifluoromethylsulfonyl)-guanidine (9.2 mg, 0.024 mmol) at rt 
and the reaction mixture was left to stir for 24 h. The mixture was quenched with saturated 
aqueous NaHCO3 solution (10 mL) and then extracted with CH2Cl2 (3 × 20 mL).  The 
combined organic extracts were washed with brine and dried (MgSO4) before being 
concentrated in vacuo. The concentrated residue was purified by column chromatography 
using gradient elution from CH2Cl2 to CH2Cl2/MeOH (9:1) to give a white gum (7.9 mg, 
0.013 mmol, 54% yield). Rf  = 0.45 in MeOH/CH2Cl2 (1:9). 
1H NMR δ 4.44 (br s, 1H, H-2), 
4.15 (s, 3H, O-CH3), 3.73 (d, J 13.5 Hz, 2H, H-1′), 3.54 (br s, 1H, H-9a), 3.28-3.22 (m, 1H, 
H-5a), 3.12-3.04 (m, 2H, H-5b, H-10), 3.08 (s, 3H, N-CH3), 2.74 (d, J 5.5 Hz, 1H, H-7), 2.08 
(s, 3H, H-16), 2.01 (d, J 12.5 Hz, 1H, H-1a), 1.99-1.89 (m, 2H, H-6), 1.83 (dd, J 10.0 Hz, 3.5 
Hz, 1H, H-9), 1.75 (d, J 12.0 Hz, 1H, H-1b), 1.67 (br s, 1H, NH), 1.47 (s, 18H, CO2C(CH3)3), 
1.39 (d, J 6.5 Hz, 3H, H-17). 13C NMR (The signals for C-1′′ and the Boc carbonyls were not 
observed.) δ 169.6 (C-15), 162.6 (C-13), 147.6 (C-12), 128.0 (C-11), 112.0 (C-8), 98.7 (C-
14), 83.8 (C-3), 76.5 (C-2), 60.2 (C-9a), 58.9 (O-CH3), 52.4 (C-1′), 50.4 (C-7), 47.8 (C-5), 
47.5 (C-9), 40.0 (N-CH3), 34.2 (C-10), 33.4 (C-1), 28.2 (CO2C(CH3)3), 26.4 (C-6), 18.2 (C-
17), 9.1 (C-16). ESIMS m/z 616.6 (100%) [M+H]+, 617.4 (80%). HRESIMS m/z 617.3188 







2(5H)-furanoyl hydrochloride (25). To a solution of 24 (7.9 mg, 0.013 mmol) in dry 
CH2Cl2 (1.0 mL) was added TFA (1.0 mL) at rt and the reaction mixture was left to stir for 3 
h. The solvent was removed under vacuum. To the residue was added hydrogen chloride in 
ether (2.0 mL, 1 M) and concentrated under vacuum. The desired product was isolated as its 
hydro chloride salt by dissolution in MeOH and precipitation by the addition of diethyl ether 
as a white solid salt (4.3 mg, 0.010 mmol, 52% yield). [α] 25D  +191.2 (c 0.23, CH3OH). 
1H 
NMR (CD3OD, a very broad spectrum was observed, therefore only the methyl signals are 
reported) δ 4.23 (s, 3H, O-CH3), 3.25 (s, 3H, N-CH3), 2.07 (s, 3H, H-16), 1.47 (d, J 6.0 Hz, 
3H, H-17). 13C NMR (CD3OD) The signals for carbons at C-3, C-5, C-9 and C-9a were not 
observed. δ 172.0 (C-15), 164.8 (C-13), 160.0 (C-1′′), 149.7 (C-12), 129.4 (C-11), 112.5 (C-
8), 99.6 (C-14), 76.5 (C-2), 58.9 (O-CH3), 51.0 (C-7), 47.3 (C-1′), 38.8 (C-10), 34.3 (N-CH3), 
32.2 (C-1), 24.4 (C-6), 16.8 (C-17), 7.9 (C-16). ESIMS m/z 416.7 (100%) [M+H]+. 
HRESIMS m/z 417.2155 [M+H]+, calcd for C21H29N4O5 417.2138. 
 
3.1.24 Alkynylation reaction: Preparation of (5Z)-5-[(2S,2aR,6S,7aS,7bR,8R,9S)-
hexahydro-7b-1-ethynyl-9-methyl-4H-2,2,6-(epoxy[1]propanyl[3]ylidene)furo[2,3,4-
gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-2(5H)-furanone (26). To a mixture of the 
aldehyde 2 (151 mg, 0.420 mmol) and K2CO3 (69.7 mg, 0.504 mmol) in MeOH:MeCN (1:3) 
(8.0 mL) at rt was added the Bestmann-Ohira reagent (97 mg, 0.504 mmol) and the reaction 
mixture was left to stir for 24 h. The mixture was quenched with saturated aqueous NaHCO3 
solution (10 mL) and was extracted with diethyl ether (3 × 20 mL). The combined organic 
extracts were washed with brine and dried over MgSO4 before being concentrated in vacuo. 
The concentrated residue was purified by column chromatography using gradient elution 
from CH2Cl2 to CH2Cl2/MeOH (98:2) to give 26 as a white gum (113.2 mg, 0.319 mmol, 
76% yield). A small sample was crystallized from CH2Cl2. Mp 174-176 °C (decomposed). Rf  
= 0.30 in MeOH/EtOAc (1:9). [α] 25D  +292.8 (c 0.66, CHCl3). IR νmax 3249, 2958, 2917, 2366, 
1744, 1627 cm-1. 1H NMR (CDCl3) δ 4.57 (br s, 1H, H-2), 4.13 (s, 3H, O-CH3), 3.51 (br s, 
1H, H-9a), 3.40-3.34 (m, 1H, H-5a), 3.11-3.05 (m, 2H, H-5b, H-10), 3.04 (d, J 6.0 Hz, 1H, 
H-7), 2.54 (s, 1H, H-2′), 2.17-2.10 (m, 1H, H-6a), 2.06 (s, 3H, H-16), 2.00 (d, J 12.5 Hz, 1H, 
H-1a), 1.91 (dt, J 12.5 Hz, 3.0 Hz, 1H, H-1b), 1.89-1.84 (m, 1H, H-6b), 1.77 (dd, J 10.0 Hz, 
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3.0 Hz, 1H, H-9), 1.36 (d, J 6.5 Hz, 3H, H-17). 13C NMR (CDCl3) δ 169.7 (C-15), 162.8 (C-
13), 147.8 (C-12), 128.2 (C-11), 112.0 (C-8), 98.9 (C-14), 81.2 (C-3), 80.9 (C-2), 75.2 (C-1′), 
74.6 (C-2′), 60.7 (C-9a), 59.0 (O-CH3), 54.4 (C-7), 48.6 (C-5), 47.3 (C-9), 34.6 (C-10), 33.5 
(C-1), 27.0 (C-6), 18.3 (C-17), 9.3 (C-16). ESIMS m/z 356.1 (100%) [M+H]+. HRESIMS m/z 
356.1459 [M+H]+, calcd for C20H22NO5 356.1498.  
 
3.1.25 Click reaction method A: Preparation of (5Z)-5-[(2S,2aR,6S,7aS,7bR,8R,9S)-
hexahydro-7b-1-(1-benzyl-1H-1,2,3-triazol-4-yl)-9-methyl-4H-2,2,6-
(epoxy[1]propanyl[3]ylidene)furo[2,3,4-gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-
2(5H)-furanone (27). A mixture of the alkyne 26 (12.7 mg, 0.034 mmol), benzylbromide 
(4.8 µL, 0.040 mmol), sodium azide (2.6 mg, 0.040 mmol) and copper powder (2.0 mg) in 
tBuOH:H2O (1:1) (1.0 mL) was treated with 1M aqueous CuSO4 (0.1 mL). The mixture was 
stirred and heated in a microwave reactor at 125 °C for 10 min (10 W). The mixture was 
quenched with saturated aqueous NaHCO3 solution (10 mL) and was directly extracted with 
diethyl ether (3 × 20 mL).  The combined organic extracts were washed with brine and dried 
(MgSO4) before being concentrated in vacuo. The concentrated residue was purified by 
column chromatography using gradient elution from CH2Cl2 to CH2Cl2/MeOH (9:1) to give a 
yellow gum (3.8 mg, 0.008 mmol, 23% yield). Rf  = 0.11 in MeOH/EtOAc (5:95). [α]
25
D  
+207.6 (c 0.25, CHCl3). 
1H NMR δ 7.34 (s, 1H, C-5′), 7.32-7.28 (m, 3H, ArH), 7.22-7.21 (m, 
2H, ArH), 5.44 (d, J 2.5 Hz, 2H, C-1′′), 4.41 (br s, 1H, H-2), 4.07 (s, 3H, O-CH3), 3.51 (br s, 
1H, H-9a), 3.30 (d, J 5.5 Hz, 1H, H-7), 3.09-3.04 (m, 1H, H-10), 3.03-2.99 (m, 2H, H-5), 
2.00 (s, 3H, H-16), 1.96 (d, J 12.0 Hz, 1H, H-1a), 1.92-1.86 (m, 3H, H-1b, H-6a, H-9), 1.84-
1.81 (m, 1H, H-6b), 1.33 (d, J 6.5 Hz, 3H, H-17). 13C NMR δ 169.8 (C-15), 162.9 (C-13), 
148.3 (C-12), 147.8 (ArC), 134.5 (C-4′), 129.2 (ArCH), 128.9 (ArCH), 128.3 (ArCH), 128.1 
(C-11), 120.9 (C-5′), 112.7 (C-8), 98.7 (C-14), 81.0 (C-2), 79.9 (C-3), 61.1 (C-9a), 59.0 (O-
CH3), 54.4 (C-1′′), 52.1 (C-7), 48.6 (C-5), 47.7 (C-9), 34.6 (C-10), 33.3 (C-1), 27.2 (C-6), 
18.4 (C-17), 9.2 (C-16). ESIMS m/z 489.1 (100%) [M+H]+. HRESIMS m/z 489.2121 




10-ylidene]-4-methoxy-3-methyl-2(5H)-furanone (28). Prepared using method A, from the 
alkyne 26 (15.0 mg, 0.042 mmol), bromopropylbenzene (9 µL, 0.060 mmol), sodium azide 
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(3.9 mg, 0.060 mmol), copper powder (2.5 mg), tBuOH/H2O (1:1) (1.0 mL) and 1M aqueous 
CuSO4 (0.1 mL). The mixture was heated in a microwave reactor at 125 °C for 10 min (10 
W). The product was obtained as a white gum (4.0 mg, 0.008 mmol, 18% yield). Rf  = 0.22 in 
MeOH/EtOAc (2:8). [α] 25D  +178.4 (c 0.27, CHCl3). 
1H NMR δ 7.40 (s, 1H, H-5′), 7.21 (d, J 
8.0 Hz, 2H, ArH), 7.13 (t, J 7.5 Hz, 2H, ArH), 7.09 (d, J 7.5 Hz, 1H, ArH), 4.42 (br s, 1H, H-
2), 4.27 (t, J 7.0 Hz, 2H, H-1′′), 4.08 (s, 3H, O-CH3), 3.53 (br s, 1H, H-9a), 3.30 (d, J 6.0 Hz, 
1H, H-7), 3.10-3.06 (m, 1H, H-10), 3.06-3.02 (m, 2H, H-5), 2.60 (t, J 7.5 Hz, 2H, H-3′′), 2.18 
(quint, J 7.5 Hz, 2H, H-2′′), 2.00 (s, 3H, H-16), 1.99 (d, J 14.0 Hz, 1H, H-1a), 1.90-1.87 (m, 
2H, H-1b, H-6a), 1.86-1.82 (m, 2H, H-6b, H-9), 1.34 (d, J 6.5 Hz, 3H, H-17). 13C NMR δ 
169.8 (C-15), 162.9 (C-13), 148.3 (C-12), 147.3 (C-4′), 140.2 (ArC), 128.6 (ArCH), 128.5 
(ArCH), 128.0 (C-11), 126.4 (ArCH), 121.0 (C-5′), 112.6 (C-8), 98.6 (C-14), 81.0 (C-2), 79.8 
(C-3), 61.1 (C-9a), 59.0 (O-CH3), 52.1 (C-7), 49.7 (C-1′′), 47.7 (C-9), 47.5 (C-5), 34.6 (C-
10), 33.3 (C-1), 32.6 (C-3′′), 31.6 (C-2′′), 27.2 (C-6), 18.3 (C-17), 9.2 (C-16). ESIMS m/z 
517.4 (100%) [M+H]+. HRESIMS m/z 517.2439 [M+H]+, calcd for C29H33N4O5 517.2451. 
 
3.1.27 Click reaction Method B: Preparation of (5Z)-5-[(2S,2aR,6S,7aS,7bR,8R,9S)-
hexahydro-7b-1-(1-phenyl-1H-1,2,3-triazol-4-yl)-9-methyl-4H-2,2,6-
(epoxy[1]propanyl[3]ylidene)furo[2,3,4-gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-
2(5H)-furanone (29). To a solution of the alkyne 26 (16.2 mg, 0.046 mmol), Cu(OAc)3 (0.8 
mg, 0.005 mmol) and sodium ascorbate (13.6 mg, 0.068 mmol) in MeOH:H2O (1:1) (1.0 mL) 
at rt was added 0.09 M phenylazide in MeOH (1.0 mL) and the reaction mixture was left to 
stir for 3 h. The mixture was quenched with saturated aqueous NaHCO3 solution (10 mL) and 
was directly extracted with CH2Cl2 (3 × 20 mL).  The combined organic extracts were 
washed with brine and dried (MgSO4) before being concentrated in vacuo. The concentrated 
residue was purified by column chromatography using gradient elution from CH2Cl2 to 
CH2Cl2/MeOH (9:1) to give a yellow gum (7.2 mg, 0.015 mmol, 33% yield). Rf  = 0.37 in 
MeOH/CH2Cl2 (1:9). [α]
25
D  +229.9 (c 0.48, CHCl3). 
1H NMR δ 7.95 (s, 1H, H-5′), 7.74 (d, J 
8.0 Hz, 2H, ArH), 7.54-7.51 (m, 2H, ArH), 7.44 (t, J 7.5 Hz, 1H, ArH), 4.58 (s, 1H, H-2), 
4.16 (s, 3H, O-CH3), 3.64 (br s, 1H, H-9a), 3.50 (d, J 5.5 Hz, 1H, H-7), 3.24-3.12 (m, 3H, H-
5, H-10), 2.12-2.07 (m, 1H, H-1a), 2.09 (s, 3H, H-16), 2.05-2.02 (m, 2H, H-1b, H-6a), 2.00-
1.98 (m, 1H, H-6b), 1.97-1.93 (m, 1H, H-9), 1.43 (d, J 7.0 Hz, 3H, H-17). 13C NMR (one 
ArCH was not observed due to peak overlap) δ 169.8 (C-15), 163.0 (C-13), 148.3 (C-12), 
137.1 (ArC), 129.9 (ArCH), 128.9 (C-11), 128.2 (C-4′), 120.6 (ArCH), 119.4 (C-5′), 112.7 
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(C-8), 98.9 (C-14), 81.2 (C-2), 80.0 (C-3), 61.3 (C-9a), 59.0 (O-CH3), 52.3 (C-7), 48.7 (C-5), 
47.9 (C-9), 34.7 (C-10), 33.4 (C-1), 27.3 (C-6), 18.5 (C-17), 9.3 (C-16). ESIMS m/z 475.1 





2(5H)-furanone (30). Prepared using method B, from the alkyne 26 (12.1 mg, 0.034 mmol), 
N-propylphthalimide azide (0.50 mL, 0.187 M in THF, 0.068 mmol), sodium ascorbate (10 
mg, 0.051 mmol) and Cu(OAc)2 (0.6 mg, 0.003 mmol). The product was obtained as a 
colourless gum (9.1 mg, 0.016 mmol, 46% yield). Rf  = 0.15 in MeOH/EtOAc (1:9). [α]
25
D  
+131.4 (c 0.61, CHCl3). 
1H NMR δ 7.76-7.74 (m, 2H, ArH), 7.67-7.66 (m, 2H, ArH), 7.65 (s, 
1H, H-5′), 4.41 (br s, 1H, H-2), 4.34 (t, J 7.0 Hz, 2H, H-1′′′), 4.08 (s, 3H, O-CH3), 3.66 (t, J 
6.5 Hz, 2H, H-3′′′), 3.53 (br s, 1H, H-9a), 3.26 (d, J 6.0 Hz, 1H, H-7), 3.10-3.00 (m, 3H, H-5, 
H-10), 2.27 (quint, J 6.5 Hz, 2H, H-2′′′), 1.98 (s, 3H, H-16), 1.93-1.89 (m, 1H, H-1b), 1.85-
1.80 (m, 4H, H-1a, H-6, H-9), 1.33 (d, J 6.5 Hz, 3H, H-17). 13C NMR δ 169.5 (C-15), 168.0 
(C-1′′, C-3′′), 162.7 (C-13), 148.1 (C-12), 147.0 (C-4′), 134.0 (ArCH), 131.6 (ArC), 127.6 (C-
11), 123.1 (ArCH), 121.6 (C-5′), 112.4 (C-8), 98.2 (C-14), 80.7 (C-2), 79.5 (C-3), 60.8 (C-
9a), 58.7 (O-CH3), 51.8 (C-7), 48.2 (C-5), 47.6 (C-1′′′), 47.3 (C-9), 34.8 (C-3′′′), 34.4 (C-10), 
33.0 (C-1), 29.0 (C-2′′′), 26.9 (C-6), 18.0 (C-17), 8.9 (C-16). ESIMS m/z 586.4 (100%) 
[M+H]+. HRESIMS m/z 586.2318 [M+H]+, calcd for C31H32N5O7 586.2302. 
 
3.1.29 Click reaction Method C: Preparation of (5Z)-5-[(2S,2aR,6S,7aS,7bR,8R,9S)-
hexahydro-7b-1-(3-phenylisoxazol-5-yl)-9-methyl-4H-2,2,6-
(epoxy[1]propanyl[3]ylidene)furo[2,3,4-gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-
2(5H)-furanone (31). To a solution of the alkyne 26 (15.1 mg, 0.042 mmol), Cu(OAc)2 (3.1 
mg, 0.017 mmol) and sodium ascorbate (12.6 mg, 0.064 mmol) in EtOH:H2O (1:1) (1.0 mL) 
at rt was added N-hydroxybenzenecarboximidoyl chloride (10 mg, 0.064 mmol) and sodium 
hydroxide (2.6 mg, 0.064 mmol). The reaction was left to stir for 3 h. The mixture was 
quenched with saturated aqueous NaHCO3 solution (10 mL) and was directly extracted with 
CH2Cl2 (3 × 20 mL).  The combined organic extracts were washed with brine and dried 
(MgSO4) before being concentrated in vacuo. The concentrated residue was purified by 
column chromatography using gradient elution from CH2Cl2 to CH2Cl2/MeOH (9:1) to give a 
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white gum (11.9 mg, 0.025 mmol, 59% yield). Rf  = 0.37 in MeOH/EtOAc (1:9). [α]
25
D  
+203.4 (c 0.79, CHCl3). 
1H NMR δ 7.82-7.79 (m, 2H, ArH), 7.45 (br s, 3H, ArH), 6.56 (s, 
1H, H-4′), 4.62 (s, 1H, H-2), 4.16 (s, 3H, O-CH3), 3.65 (br s, 1H, H-9a), 3.43 (d, J 5.5 Hz, 
1H, H-7), 3.29-3.24 (m, 1H, H-5b), 3.19-3.14 (m, 2H, H-5a, H-10), 2.11-2.08 (m, 1H, H-1a), 
2.09 (s, 3H, H-16), 2.03-1.96 (m, 3H, H-1a, H-6), 1.93 (dd, J 9.5 Hz, 2.5 Hz, 1H, H-9), 1.43 
(d, J 6.0 Hz, 3H, H-17). 13C NMR δ 171.2 (C-5′), 169.7 (C-15), 162.8 (C-13), 162.6 (C-3′), 
147.8 (C-12), 130.3 (ArC), 128.9 (ArC), 128.8 (ArC), 128.3 (C-11), 127.5 (ArC), 112.5 (C-
8), 100.2 (C-4′), 99.0 (C-14), 80.6 (C-3), 80.1 (C-2), 61.3 (C-9a), 59.0 (O-CH3), 52.3 (C-7), 
49.0 (C-5), 47.7 (C-9), 34.6 (C-10), 33.3 (C-1), 27.2 (C-6), 18.4 (C-17), 9.3 (C-16). ESIMS 





ylidene]-4-methoxy-3-methyl-2(5H)-furanone (32). Prepared using method C, from the 
alkyne 26 (10.6 mg, 0.030 mmol), N-hydroxy-4-fluorobenzenecarboximidoyl chloride (20 
mg, 0.153 mmol), sodium ascorbate (8.8 mg, 0.045 mmol), sodium hydroxide (1.8 mg, 0.045 
mmol) and Cu(OAc)2 (2.2 mg, 0.012 mmol). The product was obtained as a yellow gum (6.3 
mg, 0.013 mmol, 43% yield). Rf  = 0.62 in MeOH/EtOAc (2:8). [α]
25
D  +236.1 (c 0.36, CHCl3). 
1H NMR δ 7.80-7.77 (m, 2H, ArH), 7.15 (t, J 8.5 Hz, 2H, ArH), 6.52 (s, 1H, H-4′), 4.61 (br s, 
1H, H-2), 4.16 (s, 3H, O-CH3), 3.65 (br s, 1H, H-9a), 3.42 (d, J 5.5 Hz, 1H, H-7), 3.29-3.23 
(m, 1H, H-5), 3.19-3.12 (m, 2H, H-5, H-10), 2.11 (s, 1H, H-1a), 2.09 (s, 3H, H-16), 2.04-1.96 
(m, 3H, H1b, H-6), 1.93 (dd, J 10.0 Hz, 3.0 Hz, 1H, H-9), 1.42 (d, J 6.5 Hz, 3H, H-17). 13C 
NMR δ 171.5 (C-5′), 169.7 (C-15), 164.0 (ArC-F, d, JC-F 250 Hz), 162.8 (C-13), 161.7 (C-3′), 
147.8 (C-12), 128.9 (ArCH d, JC-F 9.8 Hz), 128.8 (ArCH), 128.3 (C-11), 125.1 (ArC, d, JC-F 
3.3 Hz), 116.3 (ArCH, d, JC-F 22.0 Hz), 116.1 (ArCH), 112.4 (C-8), 100.1 (C-4′), 99.0 (C-
14), 80.6 (C-3), 80.1 (C-2), 61.3 (C-9a), 59.0 (O-CH3), 52.3 (C-7), 49.0 (C-5), 47.7 (C-9), 
34.6 (C-10), 33.3 (C-1), 27.2 (C-6), 18.4 (C-17), 9.3 (C-16). ESIMS m/z 492.9 (100%) 
[M+H]+. HRESIMS m/z 493.1789 [M+H]+, calcd for C27H26N2O6F 493.1775. 
 






A solution mixture of the alkyne 26 (13.4 mg, 0.038 mmol), iodobenzene (4.2 µL, 0.038 
mmol), PdCl2(PPh3)2 (0.5 mg, 0.001 mmol), CuI (0.3 mg, 0.002 mmol) and Et3N (19 mg, 
0.189 mmol) in THF (1.0 mL) in a glass tube was bubbled with argon gas and then the tube 
was sealed. The reaction was left to stir at rt for 24 h. The mixture was extracted with EtOAc 
(3 X 20 mL). The combined organic phase was dried (Na2SO4). The crude residue was 
purified by PTLC with MeOH/CH2Cl2 (1:99) as a mobile phase to give a phenyl alkyne 
product 33 as a yellow gum (10.0 mg, 0.023 mmol, 62% yield) and the dimeric by-product 34 
(0.6 mg, 0.0001 mmol, 4% yield) which was directly prepared via the Eglington coupling 
reaction. Rf  = 0.42 in MeOH/EtOAc (1:9). [α]
25
D  +235.9 (c 0.44, CHCl3). 
1H NMR δ 7.45-
7.44 (m, 2H, ArH), 7.31-7.30 (m, 3H, ArH), 4.66 (br s, 1H, H-2), 4.15 (s, 3H, O-CH3), 3.56 
(br s, 1H, H-9a), 3.48-3.42 (m, 1H, H-5a), 3.14 (d, J 6.0 Hz, 1H, H-7), 3.11-3.08 (m, 2H, H-
5b, H-10), 2.23-2.17 (m, 1H, H-6a), 2.08 (s, 3H, H-16), 2.06 (d, J 12.0 Hz, 1H, H-1a), 1.98 
(d, J 12.0 Hz, 1H, H-1b), 1.93-1.88 (m, 1H, H-6b), 1.83 (d, J 10.0 Hz, 1H, H-9), 1.39 (d, J 
6.5 Hz, 3H, H-17). 13C NMR δ 169.8 (C-15), 162.9 (C-13), 148.0 (C-12), 131.9 (ArCH), 
128.6 (ArCH), 128.4 (ArCH), 128.2 (C-11), 122.5 (ArC), 112.2 (C-8), 98.9 (C-14), 86.3 (C-
2′), 86.1 (C-1′), 81.2 (C-2), 76.0 (C-3), 60.8 (C-9a), 59.0 (O-CH3), 54.6 (C-7), 48.7 (C-5), 
47.4 (C-9), 34.6 (C-10), 33.6 (C-1), 27.1 (C-6), 18.4 (C-17), 9.3 (C-16). ESIMS m/z 432.1 
(100%) [M+H]+. HRESIMS m/z 432.1821 [M+H]+, calcd for C26H26NO5 432.1811. 
 
3.1.32 Eglington coupling: Preparation of Bis-(5Z)-5-[(2S,2aR,6S,7aS,7bR,8R,9S)-
hexahydro-7b-1-ethynyl-9-methyl-4H-2,2,6-(epoxy[1]propanyl[3]ylidene)furo[2,3,4-
gh]pyrrolizin-10-ylidene]-4-methoxy-3-methyl-2(5H)-furanone (34). 
A solution of the alkyne 26 (13.5 mg, 0.038 mmol) and Cu(OAc)2 (35 mg, 0.190 mmol) in 
dry MeCN (1.0 mL) in a sealed tube was bubbled with argon gas and then the tube was 
sealed. The reaction mixture was heated and stirred at 40 °C for 4 h. The mixture was cooled 
to rt and filtered through a thin pad of Celite. The filtrate was treated with an aqueous 
solution of NaHCO3 and extracted with CH2Cl2 (3 × 20 mL). The combined organic phase 
was washed with brine and dried (MgSO4). The evaporated residue was purified by PTLC 
with MeOH/CH2Cl2 (2:98) as a mobile phase to give a dimer 34 as a yellow gum (12.0 mg, 
0.017 mmol, 89% yield). Rf  = 0.50 in MeOH/CH2Cl2 (1:9). [α]
25
D  +286.3 (c 0.39, CHCl3). 
1H 
NMR δ 4.56 (br s, 2H, H-2), 4.13 (s, 6H, O-CH3), 3.50 (br s, 2H, H-9a), 3.37-3.31 (m, 2H, H-
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5a), 3.10-3.02 (m, 4H, H-5b, H-10), 3.05 (d, J 6.0 Hz, 2H, H-7), 2.14-2.08 (m, 2H, H-6a), 
2.06 (s, 6H, H-16), 2.00 (d, J 12.0 Hz, 2H, H-1a), 1.89-1.86 (m, 2H, H-1b), 1.85-1.83 (m, 2H, 
H-6b), 1.76 (dd, J 10.5 Hz, 3.5 Hz, 2H, H-9), 1.35 (d, J 6.5 Hz, 6H, H-17). 13C NMR δ 169.7 
(C-15), 162.8 (C-13), 147.6 (C-12), 128.2 (C-11), 111.9 (C-8), 99.0 (C-14), 80.9 (C-2), 77.4 
(C-3), 75.8 (C-1′), 70.4 (C-2′), 60.8 (C-9a), 59.0 (O-CH3), 54.8 (C-7), 48.9 (C-5), 47.3 (C-9), 
34.6 (C-10), 33.6 (C-1), 27.0 (C-6), 18.3 (C-17), 9.3 (C-16). ESIMS m/z 709.5 (100%) 




methyl-2(5H)-furanone (35). To a mixture of the phenyl alkyne 33 (4.7 mg, 0.011 mmol) 
and Pd/C (0.5 mg, 0.002 mmol) in EtOAc (1.0 mL) at rt, a hydrogen gas was bubbled into the 
solution and the reaction was let to stir for 24 h. The reaction mixture was then filtered 
through a thin pad of Celite. The concentrated residue was purified by PTLC with 
MeOH/EtOAc (1:99) as a mobile phase to give a product as a white gum (3.5 mg, 0.008 
mmol, 74% yield). Rf  = 0.32 in MeOH/CH2Cl2 (1:9). [α]
25
D  +248.4 (c 0.23, CHCl3). 
1H NMR 
δ 7.20 (d, J 7.0 Hz, 2H, ArH), 7.13-7.10 (m, 3H, ArH), 4.24 (br s, 1H, H-2), 4.06 (s, 3H, O-
CH3), 3.43 (br s, 1H, H-9a), 3.12-3.06 (m, 1H, H-5), 3.05-3.00 (m, 1H, H-10), 2.99-2.93 (m, 
1H, H-5), 2.72 (td, J 11.5 Hz, 5.0 Hz, 1H, H-1′), 2.66 (d, J 6.0 Hz, 1H, H-7), 2.50 (td, J 13.5 
Hz, 5.5 Hz, 1H, H-1′), 2.00 (s, 3H, H-16), 1.90 (d, J 12.0 Hz, 1H, H-6a), 1.90-1.79 (m, 3H, 
H-1a, H-9, H-2′), 1.78-1.74 (m, 2H, H-6b, H-2′), 1.67 (dt, J 12.0 Hz, 3.5 Hz, 1H, H-1b), 1.31 
(d, J 6.5 Hz, 3H, H-17). 13C NMR δ 169.8 (C-15), 162.9 (C-13), 148.5 (C-12), 141.7 (ArC), 
128.6 (ArCH), 128.3 (ArCH), 128.0 (C-11), 126.1 (ArCH), 112.7 (C-8), 98.6 (C-14), 82.7 
(C-3), 78.5 (C-2), 61.0 (C-9a), 58.9 (O-CH3), 50.4 (C-7), 47.7 (C-5, C-9), 34.6 (C-10), 33.7 
(C-2′), 33.4 (C-1), 31.4 (C-1′), 26.7 (C-6), 18.4 (C-17), 9.2 (C-16). ESIMS m/z 436.1 (100%) 
[M+H]+. HRESIMS m/z 436.2118 [M+H]+, calcd for C26H30NO5 436.2124. 
 
3.1.34 AChE inhibition studies 
3.1.34.1 TLC Bioautographic method 
The AChE used in this assay was extracted from electric eels and purchased from Sigma 
Aldrich (EC 3.1.1.7). The enzyme stock solution was prepared from a solution of AChE 
(1000 U) in 0.05 M tris-hydrochloric acid buffer (150 mL) at pH 7.8 to which was added 
bovine serum albumin (150 mg) to stabilize the enzyme. The stock solution was kept at 4 °C. 
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TLC plates used for the bioautography were washed with acetone and then thoroughly dried. 
The samples were prepared as solutions in MeOH at concentrations of 1000, 100, 10, 1 and 
0.1 ppm. The samples were applied to the TLC plates in varing quantities using Camag 
Nanomat 4 TLC spotter with 0.5 µL capillaries and sprayed with AChE enzyme stock 
solution and thoroughly dried again. The plates were laid flat on plastic plugs in a covered 
water bath (to avoid the plates from contacting the H2O directly) and then incubated in a 
humid atmosphere at 37 °C for 20 min. The plates were taken out and sprayed with a freshly 
prepared indicator solution which was a mixture of two solutions, a solution of 1-naphthyl 
acetate (25 mg) in EtOH (10 mL) and a solution of Fast Blue B salt (40 mg) in H2O (16 mL). 
After 1-2 min, a purple coloration on the TLC plates appeared and white spots indicated 
inhibition of AChE by the samples. 
 
3.1.33.2 Spectroscopic-based method 
Acetylthiocholine iodide (ATChI) was used as a substrate while 5,5′-dithiobis[2-nitrobenzoic 
acid] (DTNB) was used as a reagent. Two stock solutions were used in this assay, buffer 
solution and substrate solution. The pH 7.0 phosphate buffer solution was prepared from a 
mixture of 37.2 mM NaH2PO4⋅H2O and 62.7 mM Na2HPO4⋅2H2O, in Milli Q H2O. The 
substrate solution was prepared as a 4.73 mM ATChI solution in phosphate buffer pH 7.0. 
The reagent solution was prepared as a 3.15 mM DTNB solution in phosphate buffer pH 7.0. 
The assay was performed in 96-well plates. In each well, 120 µL of phosphate buffer pH 7.0 
was mixed with 20 µL of reagent and 20 µL of substrate, then 20 µL of AChE (0.75 U/mL) 
in phosphate buffer pH 7.0 was added with 20 µL of the sample (which was prepared in 
concentrations of 5,000, 1,000, 200, 40, 8, 1.6 and 0.32 µM in DMSO). The final 
concentrations were 500, 100, 20, 4, 0.8, 0.16 and 0.032, respectively. Then the well plate 
was directly put into the microplate reader which was thermostated at 25 °C. The absorbances 
were read using a SPECTRAmax® PLUS384 microplate thermostated spectrophotometer 
(California, USA) at 412 nm, every 15 sec for 30 min continuously. Enzyme activity was 
calculated as a percentage compared to an assay using a buffer without any inhibitor. The 
AChE inhibitory data were analyzed with the software package GraphPad Prism® (Graph Pad 
Inc., San Diego, USA). IC50 values are means ± SD of three individual determinations each 









Compound purity analysis by HPLC, synthesis of the Bestmann-Ohira reagent and the 
coupling components for the Click reactions. 
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